- Home
- ASM vs AMLX Comparison
ASM vs AMLX Comparison
Compare ASM & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASM
- AMLX
- Stock Information
- Founded
- ASM 1968
- AMLX 2014
- Country
- ASM Canada
- AMLX United States
- Employees
- ASM N/A
- AMLX N/A
- Industry
- ASM Metal Mining
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- ASM Basic Materials
- AMLX Health Care
- Exchange
- ASM Nasdaq
- AMLX Nasdaq
- Market Cap
- ASM 798.8M
- AMLX 749.9M
- IPO Year
- ASM N/A
- AMLX 2022
- Fundamental
- Price
- ASM $6.56
- AMLX $15.59
- Analyst Decision
- ASM Strong Buy
- AMLX Strong Buy
- Analyst Count
- ASM 3
- AMLX 7
- Target Price
- ASM $4.40
- AMLX $15.14
- AVG Volume (30 Days)
- ASM 6.4M
- AMLX 1.9M
- Earning Date
- ASM 11-06-2025
- AMLX 11-06-2025
- Dividend Yield
- ASM N/A
- AMLX N/A
- EPS Growth
- ASM 1940.36
- AMLX N/A
- EPS
- ASM 0.11
- AMLX N/A
- Revenue
- ASM $79,639,000.00
- AMLX N/A
- Revenue This Year
- ASM $35.34
- AMLX N/A
- Revenue Next Year
- ASM $40.41
- AMLX N/A
- P/E Ratio
- ASM $56.30
- AMLX N/A
- Revenue Growth
- ASM 53.08
- AMLX N/A
- 52 Week Low
- ASM $0.85
- AMLX $2.60
- 52 Week High
- ASM $6.67
- AMLX $15.91
- Technical
- Relative Strength Index (RSI)
- ASM 76.46
- AMLX 67.26
- Support Level
- ASM $5.00
- AMLX $13.60
- Resistance Level
- ASM $6.67
- AMLX $15.15
- Average True Range (ATR)
- ASM 0.39
- AMLX 1.02
- MACD
- ASM 0.10
- AMLX 0.00
- Stochastic Oscillator
- ASM 90.54
- AMLX 86.31
About ASM Avino Silver & Gold Mines Ltd. (Canada)
Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.